Global Viral Vector and Vaccine Market - Industry Trends and Forecast to 2027

  • Medical Devices
  • Upcoming Report
  • Jun 2020
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Viral Vector & Vaccine Market By Type (Adenovirus, Retrovirus, Plasmid DNA, AAV, Lentivirus, Others), Workflow Upstream Processing, Downstream Processing, Application (Antisense & RNAi, Gene Therapy, Cell Therapy, Vaccinology), Disease (Cancer, Genetic Disorders, Infectious Diseases, Others), End Use (Pharmaceutical and Biopharmaceutical Companies, Research Institutes), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2027

Viral Vector and Vaccine Market

Market Analysis and Insights: Global Viral Vector and Vaccine Market

Viral vector & vaccine market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to growing with the CAGR of 14.50% in the above mentioned forecast period. Rising prevalence of contagious and chronic diseases such as tuberculosis, HIV, and cancer has given a boost to market for finding effective solution for these problems whereas upcoming new disease like with outbreak of COVID-19 has raised demand for minimal invasive technique for treatment for these rising medical problems.

High transfection efficiency, effective gene delivery and stable gene expression have made viral vectors preferred choice for gene transfer and it is evident by increasing clinical trials on viral vector medicated gene therapy.

Increasing prevalence of disease such as cardiac diseases, cancer, HIV, Hemophilia has raised need for the development of therapies using viral vector whereas advancement in technology to manufacture viral vector is the key factor driving market growth. Moreover rising adoption of viral vectors by biopharmaceutical industries and increasing cost effective treatments are factor propelling market demand whereas lack of skilled professionals and high cost are factors restraining market growth. However untapped medical sector in some regions and increasing government initiatives for R&D sector of healthcare sector will produce lucrative opportunities in coming years.

This viral vector & vaccine market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on viral vector & vaccine market contact us for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Viral Vector & Vaccine Market Scope and Market Size

Viral vector & vaccine market is segmented on the basis of type, workflow, application and end use. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

  • Based on type, the viral vector & vaccine market is segmented into adenovirus, retrovirus, plasmid DNA, AAV, lentivirus, and others
  • Based on workflow, the viral vector & vaccine market is segmented into upstream processing, downstream processing. Upstream processing is further segmented into vector amplification, vector recovery. Downstream processing is further bifurcated into purification and fills finish.
  • Based on application, the viral vector & vaccine market is segmented into antisense & RNAi, gene therapy, cell therapy, and vaccinology.
  • On the basis of disease, viral vector & vaccine market is segmented into cancer, genetic disorders, infectious diseases, and others.
  • Viral vector & vaccine market has also been segmented based on end use into pharmaceutical and biopharmaceutical companies, and research institutes

Viral Vector & Vaccine Market Country Level Analysis

Viral vector & vaccine market is analysed and market size insights and trends are provided by country type, workflow, application and end use as referenced above.

The countries covered in the viral vector & vaccine market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America is anticipated to dominate the market share due to increasing infectious disease patients. Moreover approval FDA for advanced therapies such as kymriah and yescarta is contributing large revenue of US market whereas advancement of technology and presence of key players of vector manufacturing sector. Asia-Pacific is expected to be fastest growing region in forecast period due to clinical transformation and industrialization of gene therapy manufacturing.

The country section of the viral vector & vaccine market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

Viral vector & vaccine market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for viral vector & vaccine market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the viral vector & vaccine market. The data is available for historic period 2010 to 2018.

Competitive Landscape and Viral Vector & Vaccine Market Share Analysis

Viral vector & vaccine market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to viral vector & vaccine market.

The major players operating in the viral vector & vaccine market report are Novasep, MerckKGaA, Cobra Biologics Ltd., uniQure N.V., Waisman, Creative-Biogene, Aldevron, Addgene, Oxford Biomedica, Thermo Fisher Scientific Inc, Cell Therapy Catapult Limited Eurogentec, Fujifilm, Spark Therapeutics Inc. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Customization Available: Global Viral Vector and Vaccine Market

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

CHOOSE LICENCE TYPE
  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions